These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hydrodyamical assessment of valve prosthesis made of expanded ultra-microporous Teflon in vitro. Liang Y, Wang WJ, Cai KC. Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):910-1. PubMed ID: 12377616 [Abstract] [Full Text] [Related]
24. Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Koch CG, Khandwala F, Estafanous FG, Loop FD, Blackstone EH. Circulation; 2005 Jun 21; 111(24):3221-9. PubMed ID: 15956129 [Abstract] [Full Text] [Related]
25. Long-term tricuspid valve prosthesis-related complications in patients with congenital heart disease. van Slooten YJ, Freling HG, van Melle JP, Mulder BJ, Jongbloed MR, Ebels T, Voors AA, Pieper PG. Eur J Cardiothorac Surg; 2014 Jan 21; 45(1):83-9. PubMed ID: 23686501 [Abstract] [Full Text] [Related]
26. Prosthesis patient mismatch in aortic valve replacement: possible but pertinent? Taggart DP. Eur Heart J; 2006 Mar 21; 27(6):644-6. PubMed ID: 16455673 [No Abstract] [Full Text] [Related]
27. Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis. A three-year experience. Nicoloff DM, Emery RW, Arom KV, Northrup WF, Jorgensen CR, Wang Y, Lindsay WG. J Thorac Cardiovasc Surg; 1981 Nov 21; 82(5):674-83. PubMed ID: 7300400 [Abstract] [Full Text] [Related]
28. [Quality in aortic valve replacement--how good have hybrid valves have to be?]. Aicher D, Groesdonk HV, Schäfers HJ. Dtsch Med Wochenschr; 2009 Oct 21; 134 Suppl 6():S200-2. PubMed ID: 19834841 [Abstract] [Full Text] [Related]
29. The "ideal" replacement heart valve. Sapirstein JS, Smith PK. Am Heart J; 2001 May 21; 141(5):856-60. PubMed ID: 11320378 [No Abstract] [Full Text] [Related]
33. The future of heart valve standards. Nolan SP. J Heart Valve Dis; 1998 Mar 21; 7(2):123-4. PubMed ID: 9587850 [No Abstract] [Full Text] [Related]
34. Original expectations of the Hancock valve and 20 years of clinical reality. Bortolotti U, Milano A, Thiene G, Mazzucco A. Eur J Cardiothorac Surg; 1992 Mar 21; 6 Suppl 1():S75-8. PubMed ID: 1389284 [Abstract] [Full Text] [Related]
35. [Thrombosis prevention and platelet functions following heart valve replacement]. Aosaki M, Kitamura N. Nihon Rinsho; 1978 Dec 10; 36(12):3874-83. PubMed ID: 372627 [No Abstract] [Full Text] [Related]
36. Is prosthesis-patient mismatch a clinically relevant entity? David TE. Circulation; 2005 Jun 21; 111(24):3186-7. PubMed ID: 15967858 [No Abstract] [Full Text] [Related]
37. Thrombosed St. Jude Medical valve prosthesis in the right side of the heart in patients with tetralogy of Fallot. Miyamura H, Kanazawa H, Hayashi J, Eguchi S. J Thorac Cardiovasc Surg; 1987 Jul 21; 94(1):148-50. PubMed ID: 3600001 [Abstract] [Full Text] [Related]
38. Three-year clinical results with the Monostrut Björk-Shiley prosthesis. Lindblom D, Lindblom U, Henze A, Björk VO, Semb BK. J Thorac Cardiovasc Surg; 1987 Jul 21; 94(1):34-43. PubMed ID: 3600006 [Abstract] [Full Text] [Related]
39. [Short- and mean results of mitral and aortic valve replacement with a Björk-Shiley disc prosthesis. Thromboembolic and hemorrhagic complications]. Soots G, Stankowiak C, Pommier J, Warembourg HE, Watel AA. Arch Mal Coeur Vaiss; 1979 Nov 21; 72(11):1187-95. PubMed ID: 121522 [Abstract] [Full Text] [Related]